SB3221

Amends the Illinois Controlled Substances Act to add xylazine as a Class III controlled substance and provides exemptions for its use by.

Illinois SB3221 amends the Illinois Controlled Substances Act by adding xylazine to the list of Class III controlled substances. It also provides exemptions for xylazine when used by licensed Illinois veterinarians for nonhuman species, provided the drug is FDA-approved or permissible under the Federal Food, Drug, and Cosmetic Act. Xylazine is not considered a controlled substance in these specific veterinary contexts.